|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the University Department of Psychiatry, Royal Liverpool University Hospital, Liverpool, United Kingdom (CM); the Department of Pathology, Wrexham Maelor Hospital, Wrexham, United Kingdom (PH); the University Hospital of Wales, Cardiff, United Kingdom (RE); and the Wales College of Medicine, Division of General Practice, Wrexham, United Kingdom (AM)
Background: An elevated blood concentration of homocysteine is an established risk factor for cognitive impairment and dementia, but associations between cognition and methylmalonic acid (MMA), a related metabolic marker of vitamin B-12 deficiency, are less clear.
Objective: The aim was to determine the utility of serum MMA and holotranscobalamin as markers of vitamin B-12 status in relation to cognitive function and to investigate their association with discrete cognitive domains.
Design: This was a cross-sectional survey of 84 nondemented elderly participants (aged >69 y) from the Welsh cohort of the Medical Research Council's Cognitive Function and Ageing Study. Cognitive status was determined by Mini-Mental State Examination (MMSE) and the Cognitive Section of the Cambridge Mental Disorders of the Elderly Examination (CAMCOG).
Results: Nearly one-half (43%) of the persons selected had likely metabolically significant vitamin B-12 deficiency. Higher MMA concentrations were associated with lower MMSE scores independent of age and education (P = 0.007). MMA concentration correlated inversely with CAMCOG scores of ideational praxis (P < 0.05) and language comprehension (P < 0.05) and expression (P < 0.01). Serum folate correlated weakly but significantly with language (P < 0.05), remote memory (P < 0.05), and constructional and ideational praxis scores (P < 0.05 and P < 0.01, respectively).
Conclusion: The high prevalence of likely metabolically significant vitamin B-12 deficiency in the elderly is associated with lower cognitive function scores and particularly with lower scores of language comprehension and expression.
Key Words: Vitamin B-12 methylmalonic acid holotranscobalamin cognitive function Mini-Mental State Examination folate elderly aging basal ganglia language
Related articles in AJCN:
This article has been cited by other articles:
![]() |
L. Hoey, J. Strain, and H. McNulty Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1981S - 1996S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L M L de Lau, A D Smith, H Refsum, C Johnston, and M M B Breteler Plasma vitamin B12 status and cerebral white-matter lesions J. Neurol. Neurosurg. Psychiatry, February 1, 2009; 80(2): 149 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
A D. Smith and H. Refsum Vitamin B-12 and cognition in the elderly Am. J. Clinical Nutrition, February 1, 2009; 89(2): 707S - 711S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Tangney, Y. Tang, D. A. Evans, and M. C. Morris Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline Neurology, January 27, 2009; 72(4): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vogiatzoglou, H. Refsum, C. Johnston, S. M. Smith, K. M. Bradley, C. de Jager, M. M. Budge, and A. D. Smith Vitamin B12 status and rate of brain volume loss in community-dwelling elderly Neurology, September 9, 2008; 71(11): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarke, J. Birks, E. Nexo, P. M Ueland, J. Schneede, J. Scott, A. Molloy, and J. G. Evans Low vitamin B-12 status and risk of cognitive decline in older adults Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1384 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Miller Assessing the association between vitamin B-12 status and cognitive function in older adults Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1259 - 1260. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |